References
- Gilbar P, Hain A, Peereboom VM. Nail toxicity induced by cancer chemotherapy. J Oncol Pharm Pract 2009;15:143–155
- Lindsay PG. The half-and-half nail. Arch Intern Med 1967;119:583–587
- Huang WT, Wu CC. Half-and-half nail. CMAJ 2009;180:687
- Das A, Choudhury S, Pandit S, Das SK. Medical image. Half-and-half nail. N Z Med J 2012;125:103–104
- Leyden JJ, Wood MG. The “half-and-half nail” a uremic onychopathy. Arch Dermatol 1972;105:591–592
- Iorizzo M, Daniel CR, Tosti A. Half and half nails: a past and present snapshot. Cutis 2011;88:138–139
- Nixon DW, Pirozzi D, York RM, et al. Dermatologic changes after systemic cancer therapy. Cutis 1981;27:181–182, 186–188, 192–194
- Gupta A, Parakh A, Dubey AP. Chemotherapy induced nail changes. Indian J Dermatol 2008;53:204–205
- Manigand G, Faux N, Dumas D, et al. Nail pigmentation during therapy with cyclophosphamide and doxorubicin. Sem Hop 1983;59:1840–1841
- Chen W, Yu YS, Liu YH, et al. Nail changes associated with chemotherapy in children. J Eur Acad Dermatol Venereol 2007;21:186–190
- Ranawaka RR. Patterns of chromonychia during chemotherapy in patients with skin type V and outcome after 1 year follow-up. Clin Exp Dermatol 2009;34:e920–e926
- Kumar S, Dixit R, Karmakar S, Paul S. Unusual nail pigmentation following cyclophosphamide-containing chemotherapy regimen. Indian J Pharmacol 2010;42:243–244